Stock Market Today, Feb: ImmunityBio Up on Anktiva EU OK
ImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
For beginners, compare index funds and mutual funds on cost, simplicity, and diversification to choose the easier path to investing.
24,324 articlesImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
Three years can change a company’s story. Explore the signals that will determine MercadoLibre's path, focusing on fi...
PI token rockets after a major exchange adds trading, even as Bitcoin stalls below $70,000. Analysts say new liquidit...
Celebrity headlines grab attention, but the real impact is on your wallet. This article breaks down how rumors affect...
A JPMorgan analyst forecasts looming oil shortages within weeks, drawing a sharp response from investors and fund man...
Turning 50 unlocks a powerful boost for retirement savings: catch-up contributions. This guide shows you exactly how ...
Coinbase warns possible weekend disruptions as it schedules a brief system upgrade for Saturday. Traders should expec...
Big Tech’s AI investments are driving a potential $700B spend this year. This guide breaks down who wins, how to inve...
New on-chain data points to activity investor capitulation extremes for XRP, with profitability shrinking and transac...
A Live Oak Bancshares CEO sold 20,000 shares for roughly $769,000 in mid-June. Is this a warning sign or routine dive...
The week brought a roughly 10% drop for Xanadu Quantum Technologies stock as market enthusiasm cools and insiders tra...
CrowdStrike recently completed a stock split, sparking questions about its impact on liquidity and valuation. This gu...